The Manufacturers Life Insurance Company Trims Position in MetLife, Inc. (NYSE:MET)

Share on StockTwits

The Manufacturers Life Insurance Company trimmed its holdings in MetLife, Inc. (NYSE:MET) by 14.6% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 796,912 shares of the financial services provider’s stock after selling 136,072 shares during the period. The Manufacturers Life Insurance Company owned 0.09% of MetLife worth $29,621,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. OPSEU Pension Plan Trust Fund increased its stake in shares of MetLife by 3.8% during the third quarter. OPSEU Pension Plan Trust Fund now owns 8,106 shares of the financial services provider’s stock worth $301,000 after acquiring an additional 299 shares during the period. National Asset Management Inc. increased its stake in shares of MetLife by 1.5% during the third quarter. National Asset Management Inc. now owns 22,244 shares of the financial services provider’s stock worth $827,000 after acquiring an additional 322 shares during the period. Wedgewood Investors Inc. PA acquired a new position in shares of MetLife during the third quarter worth about $251,000. State Board of Administration of Florida Retirement System increased its stake in shares of MetLife by 1.2% during the third quarter. State Board of Administration of Florida Retirement System now owns 1,061,987 shares of the financial services provider’s stock worth $39,474,000 after acquiring an additional 12,323 shares during the period. Finally, Kestra Private Wealth Services LLC acquired a new position in shares of MetLife during the third quarter worth about $1,054,000. 74.92% of the stock is owned by institutional investors and hedge funds.

A number of research analysts have recently issued reports on the stock. Credit Suisse Group boosted their price target on shares of MetLife from $46.00 to $55.00 and gave the stock a “positive” rating in a research note on Tuesday, November 17th. Morgan Stanley boosted their price target on shares of MetLife from $49.00 to $53.00 and gave the stock an “overweight” rating in a research note on Wednesday. Wells Fargo & Company restated a “buy” rating and set a $45.00 target price on shares of MetLife in a research report on Thursday, August 6th. TheStreet upgraded shares of MetLife from a “c+” rating to a “b” rating in a research report on Thursday, November 5th. Finally, Barclays initiated coverage on shares of MetLife in a research report on Tuesday, November 17th. They set an “overweight” rating and a $52.00 target price on the stock. One research analyst has rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $44.88.

Shares of MET opened at $45.87 on Friday. MetLife, Inc. has a twelve month low of $22.85 and a twelve month high of $53.28. The firm has a market capitalization of $41.28 billion, a P/E ratio of 7.53, a PEG ratio of 1.67 and a beta of 1.28. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.20. The firm’s 50-day moving average is $40.47 and its two-hundred day moving average is $37.99.

MetLife (NYSE:MET) last announced its quarterly earnings results on Wednesday, November 4th. The financial services provider reported $1.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.65 by $0.08. MetLife had a net margin of 8.82% and a return on equity of 8.25%. The company had revenue of $16.51 billion for the quarter, compared to the consensus estimate of $16 billion. During the same quarter in the prior year, the firm earned $1.27 earnings per share. The company’s revenue for the quarter was down 2.4% compared to the same quarter last year. Analysts predict that MetLife, Inc. will post 5.63 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 14th. Shareholders of record on Tuesday, November 3rd will be issued a $0.46 dividend. This represents a $1.84 annualized dividend and a dividend yield of 4.01%. The ex-dividend date is Monday, November 2nd. MetLife’s dividend payout ratio (DPR) is presently 30.11%.

About MetLife

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Further Reading: What Are Treasury Bonds?

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Head to Head Comparison: Canopy Growth  vs. The Competition
Head to Head Comparison: Canopy Growth vs. The Competition
Analyzing Grocery Outlet  and China Resources Beer
Analyzing Grocery Outlet and China Resources Beer
Paringa Resources  & Hallador Energy  Critical Review
Paringa Resources & Hallador Energy Critical Review
Comparing Burlington Stores  and Sears
Comparing Burlington Stores and Sears
Navios Maritime Partners  Downgraded by Zacks Investment Research to Hold
Navios Maritime Partners Downgraded by Zacks Investment Research to Hold
Insider Selling: TransDigm Group Incorporated  Insider Sells $727,420.40 in Stock
Insider Selling: TransDigm Group Incorporated Insider Sells $727,420.40 in Stock


 
© 2006-2020 Zolmax.